Bentham Science Logo

Contents

Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued), Volume 1 - Number 2


Editorial



Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis

, 1(2): 79 - 86

Juan I. Enghelmayer, Tulio Papucci and Alejandro Raimondi


DOI: 10.2174/221270380102150520111811



Idiopathic Pulmonary Fibrosis: Treatment Strategies

, 1(2): 87 - 94

Brenda E. Varela and Gabriela C. Tabaj


DOI: 10.2174/221270380102150520112938



Idiopathic Pulmonary Fibrosis, Opportunities and Challenges

, 1(2): 95 - 98

Glenda Ernst, Borsini Eduardo and Salvado Alejandro


DOI: 10.2174/2212703802666150127002032



Randomized, Placebo Controlled Study of the Effects of Etoricoxib on Markers of Inflammation, Pain and Muscle Force After Eccentric Exercise

, 1(2): 99 - 110

Matthias Rother, Egbert Johannes Seidel, Ilka Rother and Steffen Koll


DOI: 10.2174/221270380102150520115507




Comparison of In Vitro and In Vivo Effects of Infliximab on Cytokine Production in Proliferating CD4+ T Cells in Patients with Rheumatoid Arthritis

, 1(2): 122 - 128

Syuichi Koarada, Yuri Sadanaga, Natsumi Nagao, Satoko Tashiro, Rie Suematsu, Akihide Ohta and Yoshifumi Tada


DOI: 10.2174/2212703802666150127001412



Pharmacological Screening of Lantana camara for its Antiallergic Activity in Rodents

, 1(2): 129 - 136

Manojkumar Mahajan, Vishal Gulecha and Chandrashekhar Upasani


DOI: 10.2174/221270380102150520120102





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science